Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
NCT ID: NCT00038662
Last Updated: 2006-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
200 participants
INTERVENTIONAL
2002-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atrasentan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* radical prostatectomy,
* PSA between 0.4 and 5 ng/mL,
* PSADT \< 1 year
Exclusion Criteria
* salvage therapy to the pelvis within 3 months prior to randomization
19 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darryl Sleep, M.D.
Role: STUDY_DIRECTOR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology Centers Of Alabama
Homewood, Alabama, United States
Alaska Clinical Research Center, LLC
Anchorage, Alaska, United States
Arkansas Urologial Associates, PA
Little Rock, Arkansas, United States
San Diego Urology Center
La Mesa, California, United States
Western Clinical Research Inc
Torrance, California, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
Clinical Physiology Associates
Fort Myers, Florida, United States
Southeastern Urological Center, PA
Tallahassee, Florida, United States
Northwestern University
Chicago, Illinois, United States
Johns Hopkins Oncology Center
Baltimore, Maryland, United States
Sheldon Freedman MD
Las Vegas, Nevada, United States
VA Medical Center(111)
Reno, Nevada, United States
Nevada Urology Associates
Reno, Nevada, United States
Carolinas Medical Centre
Charlotte, North Carolina, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Urologic Specialists Of Oklahoma, Inc.
Tulsa, Oklahoma, United States
Oregon Urology Specialists
Eugene, Oregon, United States
Urological Assoc. of Lancaster
Lancaster, Pennsylvania, United States
University Of Pittsburgh
Pittsburgh, Pennsylvania, United States
Center for Urologic Care
West Reading, Pennsylvania, United States
Ntouch Research Corporation
Dallas, Texas, United States
Salt Lake Research
Salt Lake City, Utah, United States
Jeffrey Frankel, M.D.
Seattle, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States
Tom Baker Cancer Center
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Cal Andreou, MD
Surrey, British Columbia, Canada
Can-Med Medical Research Inc
Victoria, British Columbia, Canada
Bruce W. Palmer Urology Inc.
Kentville, Nova Scotia, Canada
The Male Health Centres
Barrie, Ontario, Canada
Burlington Professional Centre
Burlington, Ontario, Canada
Hamilton & District Urology Association
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Quest Clinical Trials
Markham, Ontario, Canada
Guardian Medical Arts Bldg.
North Bay, Ontario, Canada
Jack Barkin, MD
North York, Ontario, Canada
The Male Health Centres
Oakville, Ontario, Canada
Sunnybrook &Women's College Health Sciens Center
Toronto, Ontario, Canada
Hopital Notre-Dame
Montreal, Quebec, Canada
Chuq Pavillon Hotel-Dieu
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M01-366
Identifier Type: -
Identifier Source: org_study_id
NCT00084994
Identifier Type: -
Identifier Source: nct_alias